These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10492662)

  • 1. Safety of itraconazole pulse therapy for onychomycosis. An update.
    De Doncker P; Gupta AK; Cel Rosso JQ; Daniel CR; Rosen T; Verspeelt J; Marynissen G; Meuleneers L; Moskovitz B; Jacko M; Shear N; Odom RB; Aly R; Scher RK; Elewski BE
    Postgrad Med; 1999 Jul; Spec No():17-25. PubMed ID: 10492662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the safety of itraconazole pulse therapy in onychomycosis and dermatomycoses.
    Gupta A; Lambert J; Revuz J; Shear N
    Eur J Dermatol; 2001; 11(1):6-10. PubMed ID: 11174129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD; Medvesovsky E; Shalev R; Biton A; Chetov T; Naimer S; Shai A; Vardy DA
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
    Kejda J
    Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole and terbinafine in perspective. From petri dish to patient.
    De Doncker P; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
    Gupta AK; Lynch LE; Kogan N; Cooper EA
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.
    Chang CH; Young-Xu Y; Kurth T; Orav JE; Chan AK
    Am J Med; 2007 Sep; 120(9):791-8. PubMed ID: 17765049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
    Angello JT; Voytovich RM; Jan SA
    Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
    Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
    Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
    Gupta AK; Ryder JE; Johnson AM
    Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous itraconazole treatment for onychomycosis and dermatomycosis: an overview of safety.
    Nolting SK; Gupta A; Doncker PD; Jacko ML; Moskovitz BL
    Eur J Dermatol; 1999; 9(7):540-3. PubMed ID: 10523732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of itraconazole pulse therapy: Brazilian multicentric study on toenail onychomycosis caused by dermatophytes.
    Ramos-e-Silva M; Marques SA; Gontijo B; Zaitz C; Campbell I; Veloso ST
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):109-16. PubMed ID: 9784035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
    Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
    Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of fluconazole for the treatment of onychomycosis.
    Brown SJ
    Ann Pharmacother; 2009 Oct; 43(10):1684-91. PubMed ID: 19776299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.